Event

Are You Exploring a Pathway to Commercialisation? Join our Webinar

MTPConnect



Register

About the Event

MTPConnect’s 2020 Seminar Series is back this month to showcase the latest ideas, issues and challenges for the medtech, biotech and pharmaceutical sector in Australia.

Please join us on 30 June for our webinar ‘Charting Your Course - Commercialising Health Innovations’, which will explore some tools and insights to smooth the pathway to success.

If you are developing and/or are looking to commercialise a medical or health innovation, then this seminar is for you.

MTPConnect Managing Director & CEO, Dr Dan Grant will share insights on clearing the hurdles faced by companies developing and commercialising health innovations.

Also joining us is Dr John Collins from Boston-based CIMIT (Consortia for Improving Medicine with Innovation and Technology) who have developed an innovation model that has supported many companies to successfully develop their product. Dr Collins will discuss the benefits of health innovation tools, such as the GAITS (Guidance and Impact Tracking System) platform, and how they have helped to create success for companies navigating commercialisation.

Health Horizon has been tracking the progress of health innovations globally since 2016 on their platform. Director & Co-Founder Marcus Dawe will discuss the importance of market intelligence/understanding the competitive landscape and touch on their platform which catalogues health innovations and how it can assist innovators.

OncoRes Medical is a WA-based medical device start-up who have developed a handheld imaging tool to help surgeons more accurately identify and remove tumours during breast cancer surgery. CEO and Managing Director Dr Kath Giles will speak about her approach to commercialising their health innovation and working with venture capital firm Brandon Capital.

AUDIENCE: digital health, medtech, biotech and pharma SMEs, start-ups, entrepreneurs, clinician and academic researchers, non-medtech looking to move into medtech, grant writers, commercialisation officers.